Oncopeptides AB (publ) (LON:0RN4)
London flag London · Delayed Price · Currency is GBP · Price in SEK
1.700
-0.014 (-0.82%)
At close: Jul 7, 2025

Oncopeptides AB Market Cap

Oncopeptides AB has a market cap or net worth of 38.68 million as of July 9, 2025. Its market cap has decreased by -16.88% in one year.

Market Cap
38.68M
Enterprise Value
40.68M
Revenue
3.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70

Market Cap Chart

Since February 22, 2017, Oncopeptides AB's market cap has decreased from 149.07M to 38.68M, a decrease of -74.05%. That is a compound annual growth rate of -14.87%.

History

DateMarket Cap% Change
Jul 8, 202538.68M59.68%
Dec 30, 202424.23M-57.05%
Dec 29, 202356.41M-38.17%
Dec 30, 202291.23M76.11%
Dec 30, 202151.80M-94.99%
Dec 30, 20201.03B80.19%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 29, 2017 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
AstraZeneca 160.28B
Shell 155.15B
HSBC Holdings 153.72B
Unilever 112.24B
Rolls-Royce Holdings 80.35B
British American Tobacco p.l.c. 77.53B
Rio Tinto Group 72.88B
RELX PLC 71.39B
Market Cap Rankings